Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "Cadila"

152 News Found

Jawed Zia appointed CEO of Cadila Pharmaceuticals Domestic Prescription Business
People | May 14, 2022

Jawed Zia appointed CEO of Cadila Pharmaceuticals Domestic Prescription Business

A seasoned professional, he will lead the strategy and business operations of Cadila’s branded prescriptions pharma business


Cadila Pharma launches world’s first three-dose rabies vaccine
News | April 08, 2022

Cadila Pharma launches world’s first three-dose rabies vaccine

The recombinant nanoparticle-based rabies G protein vaccine is prepared using virus-like particle technology.


Cadila Healthcare is now Zydus Lifesciences
News | February 24, 2022

Cadila Healthcare is now Zydus Lifesciences

Zydus unveils its ‘innovation and care’ centric corporate brand identity


Cadila Pharma launches lotion to treat dry skin conditions
News | February 11, 2022

Cadila Pharma launches lotion to treat dry skin conditions

Laglo Soft lotion comes with a unique technology that enhances moisturisation and restructures the skin


Cadila Healthcare reports Q3FY22 net profit at Rs. 500.4 Cr
News | February 03, 2022

Cadila Healthcare reports Q3FY22 net profit at Rs. 500.4 Cr

The company has reported total income of Rs. 3715.8 crores during the quarter ended December 31, 2021


Cadila Pharma launches ayurvedic energy tonic Healtherbs
Healthcare | December 08, 2021

Cadila Pharma launches ayurvedic energy tonic Healtherbs

Healtherbs helps in restoring the desired energy levels for daily activity and immunity


Cadila partners with Enzychem of South Korea to manufacture ZyCoV-D
News | November 25, 2021

Cadila partners with Enzychem of South Korea to manufacture ZyCoV-D

The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022


Zydus Cadila submits NDA to Drug Controller General of India for Chronic Kidney Disease
Biotech | November 23, 2021

Zydus Cadila submits NDA to Drug Controller General of India for Chronic Kidney Disease

The NDA for Desidustat is based on positive data from the DREAM-ND and DREAM-D Phase 3 trials in patients with Chronic Kidney Disease (CKD) Not on Dialysis and Dialysis


Zydus Cadila receives U.S.FDA approval for leukaemia injection
Drug Approval | November 18, 2021

Zydus Cadila receives U.S.FDA approval for leukaemia injection

Nelarabine is in a class of medications called antimetabolites


Zydus Cadila receives tentative approval for IBS tablets
Drug Approval | November 15, 2021

Zydus Cadila receives tentative approval for IBS tablets

The group now has 324 approvals and has so far filed over 400 ANDAs